Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
- PMID: 34871389
- PMCID: PMC9295611
- DOI: 10.1093/fampra/cmab155
Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
Abstract
Background and objectives: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of patients newly diagnosed with CRC.
Methods: Patients were recruited from the Midland region and interviewed about their diagnostic experience using a questionnaire based on a modified Model of Pathways to Treatment framework and SYMPTOM questionnaire. Descriptive statistics were used to describe the population characteristics. Chi-square analysis and logistic regression were used to analyse factors influencing diagnostic intervals.
Results: Data from 176 patients were analysed, of which 65 (36.9%) experienced a general practitioner (GP) diagnostic interval of >120 days and 96 (54.5%) experienced a total diagnostic interval (TDI) > 120 days. Patients reporting rectal bleeding were less likely to experience a long TDI (odds ratio [OR] 0.34, 95% confidence interval [CI]: 0.14-0.78) and appraisal/help-seeking interval (OR, 0.19, 95% CI: 0.06-0.59). Patients <60 were more likely to report a longer appraisal/help-seeking interval (OR, 3.32, 95% CI: 1.17-9.46). Female (OR, 2.19, 95% CI: 1.08-4.44) and Māori patients (OR, 3.18, 95% CI: 1.04-9.78) were more likely to experience a long GP diagnostic interval.
Conclusion: NZ patients with CRC can experience long diagnostic intervals, attributed to patient and health system factors. Young patients, Māori, females, and patients experiencing change of bowel habit may be at particular risk. We need to increase symptom awareness of CRC for patients and GPs. Concentrated efforts are needed to ensure equity for Māori in access to screening, diagnostics, and treatment.
Keywords: New Zealand; bowel; colorectal cancer; delayed diagnosis; general practice; questionnaire.
Plain language summary
New Zealand has high rates of colorectal cancer but low rates of early detection. We interviewed newly diagnosed patients about their diagnostic experience to identify factors influencing time to diagnosis. More than half of patients experienced a long diagnostic interval. Young patients, Māori, females, and patients experiencing changes of bowel habit may be at particular risk for long intervals. With the diagnostic difficulty of colorectal cancer (CRC), we need to increase CRC symptom awareness for patients and general practitioners.
© The Author(s) 2021. Published by Oxford University Press.
Figures
Similar articles
-
How do colorectal cancer patients rate their GP: a mixed methods study.BMC Fam Pract. 2021 Apr 8;22(1):67. doi: 10.1186/s12875-021-01427-7. BMC Fam Pract. 2021. PMID: 33832431 Free PMC article.
-
Barriers and facilitators to colorectal cancer diagnosis in New Zealand: a qualitative study.BMC Fam Pract. 2020 Oct 1;21(1):206. doi: 10.1186/s12875-020-01276-w. BMC Fam Pract. 2020. PMID: 33003999 Free PMC article.
-
Outcomes from colonoscopy following referral from New Zealand general practice: a retrospective analysis.BMC Gastroenterol. 2021 Dec 15;21(1):471. doi: 10.1186/s12876-021-02042-7. BMC Gastroenterol. 2021. PMID: 34911443 Free PMC article.
-
Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review.JBI Database System Rev Implement Rep. 2019 Nov;17(11):2265-2300. doi: 10.11124/JBISRIR-2017-003927. JBI Database System Rev Implement Rep. 2019. PMID: 31188154
-
AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review.Clin Gastroenterol Hepatol. 2020 Oct;18(11):2415-2424. doi: 10.1016/j.cgh.2020.05.058. Epub 2020 Jun 7. Clin Gastroenterol Hepatol. 2020. PMID: 32525015 Review.
References
-
- Ministry of Health. Bowel cancer: information for people at increased risk of bowel cancer. New Zealand Guidelines Group. Wellington (New Zealand): Ministry of Health; 2012.
-
- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020. [accessed 2020 October 31]. https://gco.iarc.fr/today
-
- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today: colorectal cancer. Lyon, France: International Agency for Research on Cancer; 2020. [accessed 2020 November 6]. https://gco.iarc.fr/today.
-
- Jackson C, Sharples K, Firth M, Hinder V, Jeffery M, Keating J, Secker A, Derrett S, Atmore C, Bramley D, et al. The PIPER Project: an internal examination of colorectal cancer management. Wellington (New Zealand): Health Research Council and Ministry of Health; 2015.
-
- Firth M, Blackmore T, Chepulis L, Keenan R, Stokes T, Elwood M, Weller D, Emery J, Lawrenson R. Why does New Zealand have such poor outcomes from colorectal cancer? The importance of the pre-diagnostic period. J Prim Health Care. 2021;13(1):15–26. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical